Scientists hope to give people back the use of disabled arms and legs after a world-first breakthrough allowing them to regrow the missing nerves in rats.
Trials of the technology are still in the early stages, but better-than-expected results raise prospects of saving limbs lost in accidents or eventually overcoming paraplegia and quadriplegia.
St Vincent’s Hospital researchers have built and implanted a bridge between severed nerves in areas too large and complex to be healed by conventional nerve grafts.
After successfully restoring the feeling and partial use of legs in rats missing the main nerve to their limbs, director of neurosciences Prof Mark Cook said new trials had begun to see how far the technology can allow nerves to regrow in the hope it can be expanded to humans studies in the next two to five years.
“We will have the potential to deal with a broader range and bigger injured nerves down the track,” Prof Cook said.
“Some of these gaps in humans are substantial. You can have long sections of nerves in humans because obviously their limbs are a lot longer than in animals such as rats.
“We started by focusing on the large peripheral nerves as it seems the best target and, once we have mastered that, we would be able to move on to the spinal chord. This worked better than we anticipated so we are really pleased it is something we can take to humans in the not-too-distant future.”
In conjunction with ARC Centre of Excellence for Electromaterials Science in Wollongong, the St Vincent’s team built a chamber made of polymer and containing a gel of growth factors, which is placed in a 1cm section of missing nerve to act as a bridge and restore contact between the brain and damaged sections of the body.
In recent trials the scientists were able to see rats regain partial and, when the chambers were removed after four weeks, discovered new nerves had grown to reconnect the disabled limbs to the brain.
Assoc Prof Robert Kapsa said the technology could mitigate the impact of injuries by restoring more feeling.
The Latest on: Regenerative medicine
- Translational Regenerative Medicine Market Size Was Totaled 11.87 Billion in 2016 and It Is Estimated to Reach US$ 52.94 Billion by the End of 2023 on November 12, 2018 at 10:38 pm
High medical reimbursement facilities and technological advancement in the region are considered to be the key factors driving the dominance of North America in global regenerative medicines market. T... […]
- Regenerative Medicine Market: Rising Healthcare Expenditure to Drive the Market on November 12, 2018 at 10:48 am
Albany, NY -- (SBWIRE) -- 11/12/2018 -- A large pool of elderly worldwide and the rising instances of external and internal injuries has led to increasing uptake of regenerative medicine (bone and joi... […]
- Dr. Dipnarine Maharaj - Keynote Speaker at the XVII INTERNATIONAL CONGRESS OF ANTI-AGING MEDICINE on November 12, 2018 at 8:41 am
Dr. Dipnarine Maharaj, M.D. (Hematologist/Oncologist/Transplant Physician) is a world renowned expert, the Medical Director of Maharaj Institute of Immune Regenerative Medicine (MIIRM), Boynton Beach, ... […]
- Business development drives growth of regenerative medicine on November 11, 2018 at 10:54 pm
The regenerative medicine sector that embraces gene and cell therapies continues to expand, particularly on the business and clinical development fronts. For example, a panel at the Neurosciences 2018 ... […]
- R3 Stem Cell CEO Presents at China Regenerative Medicine Symposiums on November 11, 2018 at 9:42 pm
R3 Stem Cell's Founder and CEO, David Greene MD, MBA, recently presented in front of standing only crowds at two regenerative medicine symposiums in China. SCOTTSDALE, Ariz., Nov. 12, 2018 /PRNewswire ... […]
via Google News and Bing News